Nationwide, Pragmatic, Direct-to-Patient Primary Aldosteronism Testing Program

被引:0
作者
Brown, Jenifer M. [1 ,2 ,3 ]
Tsai, Laura C. [1 ,3 ]
Abel, Eva E. [1 ,2 ,3 ]
Ferrebus, Arnaldo [1 ,3 ]
Moore, Anna E. [1 ,3 ]
Niebuhr, Yvonne M. [1 ,3 ]
Bacare, Bassil [1 ,3 ]
Honzel, Brooke [1 ,3 ]
Milks, Julia [1 ,3 ]
Foote, Kristen [1 ,3 ]
Newman, Andrew J. [1 ,3 ]
Parksook, Wasita W. [1 ,3 ,4 ,5 ,6 ]
Vaidya, Anand [1 ,3 ]
机构
[1] Harvard Med Sch, Ctr Adrenal Disorders, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
[2] Harvard Med Sch, Div Cardiovasc Med, Boston, MA 02115 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[4] Chulalongkorn Univ, Div Endocrinol & Metab, Bangkok, Thailand
[5] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand
[6] Chulalongkorn Univ, Fac Med, Dept Med, Div Gen Internal Med, Bangkok, Thailand
基金
美国国家卫生研究院;
关键词
aldosterone; blood pressure; hyperaldosteronism; hypertension; social media; PRIMARY-CARE PHYSICIANS; PLASMA-RENIN ACTIVITY; RESISTANT HYPERTENSION; CARDIOVASCULAR EVENTS; SCREENING RATES; PREVALENCE; SPIRONOLACTONE; IMPLEMENTATION; HYPOKALEMIA; EPLERENONE;
D O I
10.1161/HYPERTENSIONAHA.125.24648
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
BACKGROUND:Primary aldosteronism, an endocrinopathy present in >= 10% to 25% of patients with hypertension, confers excess cardiovascular risk that can be mitigated with aldosterone-directed therapy. However, only 2% of eligible patients undergo guideline-recommended screening. This study aimed to bypass clinical inertia and identify people with primary aldosteronism using pragmatic, direct-to-patient testing.METHODS:Hypertensive adults were recruited via online platforms and underwent virtual consent and local phlebotomy. Using a standardized diagnostic algorithm, laboratory results with interpretations were communicated to patients and primary care providers. Follow-up was ascertained at 6 to 12 months. The primary outcome was the frequency of a positive test for primary aldosteronism. Secondary outcomes included follow-up primary aldosteronism testing and implementation of aldosterone-targeted therapies.RESULTS:The study population (N=694) had a mean age of 63.3 +/- 11.3 years, was 52.2% female, and hailed from 41 US states. Overall, 25.4% had a positive test for primary aldosteronism. Sleep apnea, resistant hypertension, and hypokalemia were the most common testing indications, with 55.2% of participants having >= 2 indications. Over half of participants (57%) were already under endocrinology, cardiology, or nephrology care, yet had not been tested. In longitudinal follow-up of participants with a positive result, 25.5% had additional testing, 13.7% were started on aldosterone-targeted therapy (mineralocorticoid receptor antagonist or adrenalectomy), and 24.5% reported improved blood pressure control.CONCLUSIONS:Pragmatic, direct-to-patient testing, and simplified results interpretation is a feasible, scalable method to increase primary aldosteronism diagnoses and implementation of aldosterone-targeted therapies. Given that new hypertension guidelines recommend primary aldosteronism screening in all hypertensive people, practical approaches to test, interpret, and implement results will be essential.
引用
收藏
页码:977 / 988
页数:12
相关论文
共 74 条
[1]   Implementation Strategies to Improve Blood Pressure Control in the United States: A Scientific Statement From the American Heart Association and American Medical Association [J].
Abdalla, Marwah ;
Bolen, Shari D. ;
Brettler, Jeffrey ;
Egan, Brent M. ;
Ferdinand, Keith C. ;
Ford, Cassandra D. ;
Lackland, Daniel T. ;
Wall, Hilary K. ;
Shimbo, Daichi .
HYPERTENSION, 2023, 80 (10) :E143-E157
[2]   SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE IN ESSENTIAL HYPERTENSION - BLOOD-PRESSURE RESPONSE AND PLASMA-RENIN ACTIVITY [J].
ADLIN, EV ;
MARKS, AD ;
CHANNICK, BJ .
ARCHIVES OF INTERNAL MEDICINE, 1972, 130 (06) :855-858
[3]   Body mass index and angiotensin-dependent control of the renal circulation in healthy humans [J].
Ahmed, SB ;
Fisher, NDL ;
Stevanovic, R ;
Hollenberg, NK .
HYPERTENSION, 2005, 46 (06) :1316-1320
[4]   Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study [J].
Bakris, George ;
Pergola, Pablo E. ;
Delgado, Belkis ;
Genov, Diyan ;
Doliashvili, Tamar ;
Vo, Nam ;
Yang, Y. Fred ;
McCabe, James ;
Benn, Vincent ;
Pitt, Bertram .
HYPERTENSION, 2021, 78 (01) :74-81
[5]   Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes [J].
Bakris, George L. ;
Agarwal, Rajiv ;
Anker, Stefan D. ;
Pitt, Bertram ;
Ruilope, Luis M. ;
Rossing, Peter ;
Kolkhof, Peter ;
Nowack, Christina ;
Schloemer, Patrick ;
Joseph, Amer ;
Filippatos, Gerasimos .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) :2219-2229
[6]   Clinical inertia and the 2017 ACA/AHA guideline [J].
Berlowitz, Dan R. .
JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (10) :1392-1394
[7]   Characterizing the Origins of Primary Aldosteronism [J].
Brown, Jenifer M. ;
Honzel, Brooke ;
Tsai, Laura C. ;
Milks, Julia ;
Neibuhr, Yvonne M. ;
Newman, Andrew J. ;
Cherney, Michael ;
Stouffer, David G. ;
Auchus, Richard J. ;
Vaidya, Anand .
HYPERTENSION, 2025, 82 (02) :306-318
[8]   The Unrecognized Prevalence of Primary Aldosteronism A Cross-sectional Study [J].
Brown, Jenifer M. ;
Siddiqui, Mohammed ;
Calhoun, David A. ;
Carey, Robert M. ;
Hopkins, Paul N. ;
Williams, Gordon H. ;
Vaidya, Anand .
ANNALS OF INTERNAL MEDICINE, 2020, 173 (01) :10-+
[9]   Prevalence of Hypokalemia and Primary Aldosteronism in 5100 Patients Referred to a Tertiary Hypertension Unit [J].
Burrello, Jacopo ;
Monticone, Silvia ;
Losano, Isabel ;
Cavaglia, Giovanni ;
Buffolo, Fabrizio ;
Tetti, Martina ;
Covella, Michele ;
Rabbia, Franco ;
Veglio, Franco ;
Pasini, Barbara ;
Williams, Tracy Ann ;
Mulatero, Paolo .
HYPERTENSION, 2020, 75 (04) :1025-1033
[10]   Plasma Renin Activity by LC-MS/MS: Development of a Prototypical Clinical Assay Reveals a Subpopulation of Human Plasma Samples with Substantial Peptidase Activity [J].
Bystrom, Cory E. ;
Salameh, Wael ;
Reitz, Richard ;
Clarke, Nigel J. .
CLINICAL CHEMISTRY, 2010, 56 (10) :1561-1569